The Concept

Biological drugs account for 10-15% of the world's pharmaceutical market and is outperforming the pharmaceutical industry as a whole with a double paced growth rate. However, unlike their small-molecule chemical drug counterparts, biologics are difficult and costly to produce with consistency, even by the same manufacturer. Among the key issues discussed are

• The many development and manufacturing challenges
• How to obtain financial support for R&D
• How to outsource smart to cut down on the length and high cost for clinical trials
• How to improve manufacturing efficiency while maintaining the safety and quality of the products

All these are becoming the gritting issues and key to success in the biopharmaceutical industry.

With a huge market made up of a population of over 3.6 billion, plus the increased number of a highly skilled workforce returning, a diverse patient pool offering cost competitive advantage (60% less than the US average) for drug development and clinical trial outsourcing and extensive tax incentives and optimistic foreign investment, Asia is set to become THE hotbed for the biotech and pharmaceutical industry!

bioLOGIC India 2007 will provide a platform for international and Asian bio-pharma industry leaders to convene and exploit opportunities offered by Asia’s growing bio industry and explore the latest trends, regulation changes, outsourcing/partnership opportunities, operational/marketing strategies and innovative technology.

Pharmaceutical and biotechnology industry leaders will find this a MUST-ATTEND event that will provide them with the opportunity to network on an interactive level amongst a stellar line-up of world-class case study presentations, panel discussions, brainstorming of strategies, and full day workshops. Industry practitioners will also have the opportunity to exchange innovative ideas, technology updates, business execution models and best-in-breed operational strategies that work best for their industry.

To provide total value to organizations, bioLOGIC India 2007 will be held over 4 days, with a pre-conference summit, one post-conference masterclass and a 2 full day main conference power-packed program addressing in detail, the gritting issues on biopharmaceutical development & manufacturing. There will also be unlimited networking opportunities.

Expect to meet a delegation of regional and international pharmaceutical and biotechnology industry executives, venture capitalists, technology vendors and legal consultants at bioLOGIC India 2007.